• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Factors V Leiden and the prothrombin gene mutation: two common genetic defects associated with thrombosis.

作者信息

Kujovich J L, Goodnight S H

出版信息

West J Med. 1998 Jun;168(6):524-5.

PMID:9655996
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1305072/
Abstract
摘要

相似文献

1
Factors V Leiden and the prothrombin gene mutation: two common genetic defects associated with thrombosis.莱顿V因子和凝血酶原基因突变：与血栓形成相关的两种常见基因缺陷。
West J Med. 1998 Jun;168(6):524-5.
2
Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.抗磷脂抗体患者中的凝血因子V莱顿突变、凝血酶原基因突变与血栓形成风险
J Rheumatol. 2002 Aug;29(8):1683-8.
3
Recurrent deep vein thrombosis and two coagulation factor gene mutations: quo vadis?
Thromb Haemost. 1999 Dec;82(6):1564-6.
4
[From gene to disease; risk factors for venous thrombosis: factor V Leiden and prothrombin 20210A].[从基因到疾病；静脉血栓形成的危险因素：凝血因子V莱顿突变和凝血酶原20210A]
Ned Tijdschr Geneeskd. 2001 Sep 22;145(38):1843-5.
5
Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis.意大利白塞病合并深静脉血栓形成患者的凝血因子V莱顿突变和凝血酶原基因G20210A突变
Arthritis Rheum. 2004 Apr 15;51(2):177-83. doi: 10.1002/art.20237.
6
Prevalence of factor V Leiden and prothrombin G20210A gene mutation.
Saudi Med J. 2005 Nov;26(11):1844.
7
Concomitant heterozygous factor V Leiden mutation and homozygous prothrombin gene variant (G20210A) in patient with cerebral venous thrombosis.脑静脉血栓形成患者同时存在杂合子因子V莱顿突变和纯合子凝血酶原基因变异（G20210A）
Med Sci Monit. 2003 May;9(5):CS41-5.
8
[Leiden, G20210A mutations in prothrombin gene and antiphospholipid antibodies in systemic lupus erythematosus and antiphospholipid syndrome].[系统性红斑狼疮和抗磷脂综合征中凝血酶原基因的 Leiden、G20210A 突变与抗磷脂抗体]
Ter Arkh. 2000;72(5):34-8.
9
Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.凝血酶原基因G20210A突变或因子V莱顿突变患者复发性静脉血栓形成的风险
Blood Coagul Fibrinolysis. 2006 Jan;17(1):23-8. doi: 10.1097/01.mbc.0000201488.33143.09.
10
Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.凝血酶原G20210A变异体和因子V莱顿突变携带者发生静脉血栓形成的风险及其与口服避孕药的相互作用。
Haematologica. 2000 Dec;85(12):1271-6.

引用本文的文献

1
Genetic and Clinical Predictors of Left Atrial Thrombus: A Single Center Case-Control Study.左心房血栓的遗传和临床预测因素：一项单中心病例对照研究。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211021171. doi: 10.1177/10760296211021171.
2
Update in internal medicine.内科学进展
Arch Med Res. 2000 Jul-Aug;31(4):329-52. doi: 10.1016/s0188-4409(00)00076-x.

本文引用的文献

1
The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis.携带凝血因子V莱顿突变且患有静脉血栓形成的患者家庭成员中静脉血栓栓塞的发生率。
Ann Intern Med. 1998 Jan 1;128(1):15-20. doi: 10.7326/0003-4819-128-1-199801010-00003.
2
A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women.
Blood. 1997 Sep 1;90(5):1747-50.
3
Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism.高同型半胱氨酸血症、凝血因子V莱顿突变与未来静脉血栓栓塞风险的相互关系。
Circulation. 1997 Apr 1;95(7):1777-82. doi: 10.1161/01.cir.95.7.1777.
4
The risk of recurrent venous thromboembolism in patients with an Arg506-->Gln mutation in the gene for factor V (factor V Leiden).凝血因子V基因（凝血因子V莱顿）中存在Arg506→Gln突变的患者发生复发性静脉血栓栓塞的风险。
N Engl J Med. 1997 Feb 6;336(6):399-403. doi: 10.1056/NEJM199702063360602.